// App-Quantinova.ai

: Gender differences in the moderating capacity of reserve and resilience factors on the association of Alzheimer’s disease brain pathology and cognitive function

Researchers

Presenter

  • Chinedu T. Udeh-Momoh

Principal Investigators

  • Bang Zheng

  • Geraint J Price

  • Celeste A de Jager

  • Catherine Robb

  • Tam J Watermeyer

  • Sima T Toopchiani

  • Jamie Ford

  • Bowen Su

  • Parthenia Giannakopoulou

  • Ziad S. Saad

  • Michael Fogle

  • Craig W. Ritchie

  • Robert Perneczky

  • Susan Baker

  • Gerald P Novak

  • Sara Ahmadi-Abhari

  • Lefkos T Middleton

Medical Centers

  • Janssen Research and Development, PA.

  • Janssen Research and Development, PA.

  • University of Edinburgh,

  • Centre for Dementia Prevention, University of Edinburgh

  • Johnson & Johnson

  • Ageing Epidemiology Research Unit, Imperial College London

  • Janssen Pharmaceutical Research and Development

  • Imperial College, London, UK

  • Northumbria University

  • Munich Cluster for Systems Neurology (SyNergy)

  • 2. Ageing Epidemiology (AGE) Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine

  • Jansse

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • Amyloid beta 42

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A